{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:51:46Z","timestamp":1793469106330,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-02128"],"award-info":[{"award-number":["2021-02128"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015-00760"],"award-info":[{"award-number":["2015-00760"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018650","name":"Percy Falk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["22 2061 Pj"],"award-info":[{"award-number":["22 2061 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["CAN 2015\/437"],"award-info":[{"award-number":["CAN 2015\/437"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.radonc.2024.110372","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T12:39:16Z","timestamp":1718023156000},"page":"110372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Quality assessment of radiotherapy in the prospective randomized SENOMAC trial"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-9971","authenticated-orcid":false,"given":"Sara","family":"Alkner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinore","family":"Wieslander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5166-8156","authenticated-orcid":false,"given":"Dan","family":"Lundstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6943-3267","authenticated-orcid":false,"given":"Martin","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2742-0887","authenticated-orcid":false,"given":"Ingrid","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8054-8847","authenticated-orcid":false,"given":"Leif","family":"Bergkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Frisell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-9543","authenticated-orcid":false,"given":"Malin","family":"Sund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Davide Gentilini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toralf","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Filtenborg Tvedskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Vrou Offersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dahl Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"de Boniface","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.radonc.2024.110372_b0005","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.ejso.2021.06.025","article-title":"Postmastectomy radiotherapy for all node positive patients: The case against","volume":"47","author":"Dixon","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.radonc.2024.110372_b0010","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.ejso.2021.06.028","article-title":"This house believes that all node positive breast cancer patients need post mastectomy radiation therapy","volume":"47","author":"Offersen","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.breast.2016.06.016","article-title":"SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes","volume":"30","author":"Tinterri","year":"2016","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.radonc.2024.110372_b0020","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.radonc.2024.110372_b0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.radonc.2024.110372_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0042-122853","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: first results following commencement of the intergroup-sentinel-mamma (INSEMA) trial","volume":"77","author":"Reimer","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.radonc.2024.110372_b0035","unstructured":"Early Breast Cancer Trialists' Collaborative, G., Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Lancet, 2023. 402(10416): p. 1991\u20132003."},{"key":"10.1016\/j.radonc.2024.110372_b0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2022.09.006","article-title":"OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial","volume":"176","author":"Algara","year":"2022","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.radonc.2024.110372_b0045","doi-asserted-by":"crossref","first-page":"e075543","DOI":"10.1136\/bmjopen-2023-075543","article-title":"Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1\u20132 sentinel node macrometastases - an open, multicentre, randomised non-inferiority phase 3 trial","volume":"13","author":"Alkner","year":"2023","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.radonc.2024.110372_b0050","doi-asserted-by":"crossref","first-page":"e054365","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"Goyal","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2024.110372_b0055","doi-asserted-by":"crossref","unstructured":"Parulekar WR, B.T., Kong I, et al, Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693). J Clin Oncol 2019. 37: p. (15_suppl):TPS602-TPS.","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS602"},{"issue":"4","key":"10.1016\/j.radonc.2024.110372_b0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.radonc.2024.110372_b0065","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"issue":"36","key":"10.1016\/j.radonc.2024.110372_b0070","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.22.00044","article-title":"Internal Mammary Node Irradiation in Patients With Node-Positive Early Breast Cancer: Fifteen-Year Results From the Danish Breast Cancer Group Internal Mammary Node Study","volume":"40","author":"Thorsen","year":"2022","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.radonc.2024.110372_b0075","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) Trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0080","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2019.08.021","article-title":"Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981\u201322023 and MA-20 field design","volume":"142","author":"Borm","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109446","article-title":"The role of ESTRO guidelines in achieving consistency and quality in clinical radiation oncology practice","volume":"179","author":"Offersen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0090","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.radonc.2022.01.010","article-title":"Personalised radiation therapy taking both the tumour and patient into consideration","volume":"166","author":"Overgaard","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110372_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.radonc.2024.110372_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-020-05537-1","article-title":"The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer","volume":"180","author":"de Boniface","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.radonc.2024.110372_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.breast.2022.02.013","article-title":"Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial","volume":"63","author":"Appelgren","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2024.110372_b0110","article-title":"Peer Christiansen, and on behalf of the SENOMAC Trialists\u2019 Group., Omitting axillary dissection in breast cancer with sentinel node metastases","author":"Jana de Boniface","year":"2024","journal-title":"New England J Med"},{"key":"10.1016\/j.radonc.2024.110372_b0115","unstructured":"Swedish Breast Cancer Radiotherapy Group. Riktlinjer f\u00f6r volymer och teknik vid str\u00e5lbehandling av br\u00f6stcancer Version 5. 2021; Available from: http:\/\/www.swebcg.se."},{"key":"10.1016\/j.radonc.2024.110372_b0120","unstructured":"Danish Breast Cancer Group. Retningslinjer - Postoperativ str\u00e5lebehandling af brystkr\u00e6ft Version 3.0. 2022; Available from: www.dbcg.dk."},{"issue":"1","key":"10.1016\/j.radonc.2024.110372_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2015.12.027","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1","volume":"118","author":"Offersen","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110372_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110372_b0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijrobp.2019.06.013","article-title":"Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes","volume":"105","author":"Adra","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.radonc.2024.110372_b0140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/0284186X.2023.2270143","article-title":"A national repository of complete radiotherapy plans: design, Results, and experiences","volume":"62","author":"Krogh","year":"2023","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110372_b0145","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: The Optimal treatment of the axilla - surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0150","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","author":"Kaidar-Person","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0155","first-page":"36","article-title":"Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study","volume":"2","author":"Eldesoky","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0160","article-title":"End-to-end framework for automated collection of large multicentre radiotherapy datasets demonstrated in a Danish Breast Cancer Group cohort","volume":"27","author":"Refsgaard","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2024.110372_b0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030751","article-title":"CANTO-RT: one of the largest prospective multicenter cohort of early breast cancer patients treated with radiotherapy including full DICOM RT Data","volume":"15","author":"Sarrade","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.radonc.2024.110372_b0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2017.03.011","article-title":"Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1","volume":"123","author":"Francolini","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110372_b0175","article-title":"Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013\u201308 trial","volume":"191","author":"Wintraecken","year":"2023","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110372_b0180","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2020.04.042","article-title":"Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial","volume":"107","author":"Hildebrandt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2024.110372_b0185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/0284186X.2014.880512","article-title":"Arm and shoulder morbidity following surgery and radiotherapy for breast cancer","volume":"53","author":"Johansen","year":"2014","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110372_b0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2023.04.020","article-title":"Regional Lymph Node Radiation Is Not the Main Risk Factor for Breast Cancer Related Lymphedema: Stop Chasing Radiation Doses, Fractionation or Techniques-Focus on Axillary Surgery De-escalation or Prevention","volume":"117","author":"Naoum","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110372_b0195","first-page":"87","article-title":"Formulation and evaluation of paclitaxel-loaded boronated chitosan\/alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery","author":"Oluwadamilola Miriam","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.radonc.2024.110372_b0200","article-title":"Difference between planned and delivered radiotherapy dose to the internal mammary nodes in high-risk breast cancer patients","volume":"27","author":"Molby Nielsen","year":"2023","journal-title":"Phys Imaging Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400642X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400642X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:04:10Z","timestamp":1778630650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402400642X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"alternative-id":["S016781402400642X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110372","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality assessment of radiotherapy in the prospective randomized SENOMAC trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110372"}}